To register, turn off your VPN; you can re-enable the VPN after registration. You must maintain an active email address on your account: disposable email addresses cannot be used to register.
I love how now that Ben has been completely proven wrong on healthcare he has to go into something so utterly irrelevant as FDA regulations.![]()
Yes, but that to is strictly regulated by the beaurocracy.
Not if you are terminally ill...
Even that needs slow and reluctant permission from the bureaucrats.
I suppose "The Liberty Bell" is ringing again? Of course, it's as usual, benvolio's "slow and reluctant […] bureaucrats" are filthy Communists, filthy Roman Catholics, filthy Jews, filthy Free Masons, filthy Immigrants, filthy Muslims, etc. etc.
You left out the filthy Mexicans. Being a bureaucrat is a job Americans won't do!
Even that needs slow and reluctant permission from the bureaucrats.
Forthcoming, and rapidly when the patient is near death.
No, the regulations of the Food and Drug Administrations are so strict that a new drug must undergo a series of tests and clinical trials before it approved for sale. The process alone costs many millions of dollars and usually takes years.
Along these lines...I would just like to point out that it was a vaccine developed in Socialist Worker's Paradise Canada that showed the greatest promise for Ebola...but I suppose that since big Pharma can't reap trillions off it...they wouldn't really care about it would they?
Thank God for the compound drug manufacturer who has stepped in to slap down the little turd Martin Schkrelly.....
Look again. Even though Cuba has developed the vaccine, it will not be available in the US without beaurocratic approval, which costs many millions of dollars. It seems likely that it will be licensed to a drug company which then will hope to recover its costs. That may be problematic since it would appear that it is too late to patent it, if it is already in the public domain.
http://www.wired.com/2015/05/cimavax-roswell-park-cancer-institute/The Obama administration has, of course, been trying to normalize relations with the island nation. And last month, during New York Gov. Andrew Cuomo’s visit to Havana, Roswell Park Cancer Institute finalized an agreement with Cuba’s Center for Molecular Immunology to develop a lung cancer vaccine and begin clinical trials in the US. Essentially, US researchers will bring the Cimavax vaccine stateside and get on track for approval by the Food and Drug Administration.
“The chance to evaluate a vaccine like this is a very exciting prospect,” says Candace Johnson, CEO of Roswell Park. She’s excited, most likely, because research on the vaccine so far shows that it has low toxicity, and it’s relatively cheap to produce and store. The Center for Molecular Immunology will give Roswell Park all of the documentation (how it’s produced, toxicity data, results from past trials) for an FDA drug application; Johnson says she hopes to get approval for testing Cimavax within six to eight months, and to start clinical trials in a year.
Look again. Even though Cuba has developed the vaccine, it will not be available in the US without beaurocratic approval, which costs many millions of dollars. It seems likely that it will be licensed to a drug company which then will hope to recover its costs. That may be problematic since it would appear that it is too late to patent it, if it is already in the public domain.

